Event Alert: An Introduction to Bronchiectasis & NTM Webinar

Posted on June 01, 2018   |   
Like 10 Likes

The COPD Foundation is convening a webinar to educate the COPD community on bronchiectasis and NTM lung disease. Join us for An Introduction to Bronchiectasis and NTM on Wednesday, June 20th from 1:00-2:00pm ET. Expert speaker, Dr. Charles Daley from National Jewish Health will provide an overview, covering the agenda items listed below, and answer questions that community members may have. This event is free, at no cost to the participants, but registration is required. Please click here to register for the event and mark your calendars! You will receive an email with connection instructions upon registering.

An Introduction to Bronchiectasis and NTM

1:00 – 1:05 pm Welcome and Introduction – COPD Foundation

1:05 – 1:20 pm Overview of COPD, Bronchiectasis and NTM – Chuck Daley, MD

· What are COPD and bronchiectasis?

o How do they relate?

o How do they differ?

· What causes these conditions?

· What are common symptoms of these conditions?

· How are they diagnosed?

1:20 – 1:30 pm Questions and Answers

1:30 – 1:45 pm Overview of COPD, Bronchiectasis and NTM – Chuck Daley, MD

· What are NTM?

· How do they relate to COPD and bronchiectasis?

· How are NTM treated in these conditions?

o How is treatment similar?

o How is treatment different?

· What resources are available for patients?

o Bronchiectasis and NTM Initiative website/community

o Bronchiectasis and NTM Information Line: 1-833-411-LUNG (5864)

o NTM Info & Research website

1:45 – 1:55 pm Questions and Answers

1:55 – 2:00 pm Closing Remarks COPD Foundation

More about your expert speaker

Daley photo.jpg Charles L. Daley, M.D.,is Professor of Medicine at National Jewish Health (NJH), the University of Colorado Denver, and Mount Sinai. He is Chief of the Division of Mycobacterial and Respiratory Infections and Director of the Nontuberculous Mycobacteria (NTM) Center of Excellence at NJH. He served as the inaugural Chair of the Bronchiectasis Research Registry and currently Chairs the revision of the ATS/IDSA/ERS/ESCMID NTM guidelines committee. Dr. Daley works closely with the World Health Organization (WHO) and the Stop TB Partnership in the global control of drug-resistant tuberculosis. He is immediate past-Chair of the Strategic and Technical Advisory Group (STAG)-TB for WHO and Chair of the Global Drug Resistance Initiative, a working group of the Stop TB Partnership and advisory body to the WHO Global TB Department. He has served on expert panels for the WHO, Centers for Disease Control and Prevention and American Thoracic Society. Dr. Daley has been recognized as one of the “Best Doctors in America” by U.S. News & World Report andCastle Connollyand he received the World Lung Health Award given by the American Thoracic Society. Dr. Daley was previously Associate Editor of the American Journal of Respiratory and Critical Care Medicine and currently Associate Editor of The European Respiratory Journal. His academic interests include global health policy and clinical and translational research in tuberculosis, NTM infections and bronchiectasis.